Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)

标题
Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)
作者
关键词
Glycaemic control, Glucagon-like peptide-1 receptor agonist, Liraglutide, Semaglutide, Type 2 diabetes, SUSTAIN
出版物
DIABETES & METABOLISM
Volume -, Issue -, Pages 101117
出版商
Elsevier BV
发表日期
2019-09-17
DOI
10.1016/j.diabet.2019.101117

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started